AbCellera Biologics Inc. ABCL Canada — Accounts Receivable
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:GovernmentAssistanceAmountCumulative.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s canada — accounts receivable.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s canada — accounts receivable?
- AbCellera Biologics Inc. (ABCL) reported canada — accounts receivable of $12.49M in Q1 2026.
- How has AbCellera Biologics Inc.'s canada — accounts receivable changed year-over-year?
- AbCellera Biologics Inc.'s canada — accounts receivable decreased by 36.6% year-over-year, from $19.68M to $12.49M.
- What does canada — accounts receivable mean?
- Represents the total outstanding balance owed to the company by customers within the Canadian segment for goods or services delivered. This metric reflects the company's ability to collect payments from its Canadian client base and serves as a key indicator of short-term liquidity and credit risk management.